Frontiers in Immunology | Vaccines and Molecular Therapeutics

Correction

Accepted on 08 Aug 2025

Correction: The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases

in Vaccines and Molecular Therapeutics

Frontiers Production Office

Frontiers in Immunology

doi 10.3389/fimmu.2025.1682368

112 views

Original Research

Accepted on 08 Aug 2025

Machine Learning Insights into Vaccine Adjuvants and Immune Outcomes

in Vaccines and Molecular Therapeutics

Yuhyun Ji
Kavitha Bekkari
Ruchin Patel
Mohammed Shardar
Geoffrey Walford
Sammoon Kim
Yaping Liu
Willis Read-Button
Kristina Tracy
Colleen Barr

Frontiers in Immunology

doi 10.3389/fimmu.2025.1654060

259 views

Original Research

Published on 08 Aug 2025

Epitope mapping using immunopeptidomics reveals novel immunodominant CD8 T cell epitopes of the AAV9 capsid

in Vaccines and Molecular Therapeutics

Akhila Balasubramanian
Marek Prachar
Birgit Klaproth
Victoria Copeland
Sune Justesen
Yi Wen
Robert W. Siegel
Laurent P. Malherbe

Frontiers in Immunology

doi 10.3389/fimmu.2025.1641289

735 views

Original Research

Published on 08 Aug 2025

Study of the influence of population immunity to tick-borne encephalitis virus on the characteristics of the epidemic process in Russia

in Vaccines and Molecular Therapeutics

Temur K. Muminov
Vladimir A. Gushchin
Denis A. Kleymenov
Artem P. Tkachuk
Viktor A. Manuylov
Andrei E. Siniavin
Daria A. Ogarkova
Nadezhda A. Kuznetsova
Vladimir I. Zlobin
Alexander L. Gintsburg

Frontiers in Immunology

doi 10.3389/fimmu.2025.1525388

337 views

Original Research

Published on 07 Aug 2025

Distinct humoral responses induced by heterologous versus homologous prime–boost immunization strategies in early life

in Vaccines and Molecular Therapeutics

Poorya Foroutan Pajoohian
Audur Anna Aradottir Pind
Jenny Lorena Molina Estupiñan
Dennis Christensen
Gabriel Kristian Pedersen
Thorunn A. Olafsdottir
Ingileif Jonsdottir
Stefania P. Bjarnarson

Frontiers in Immunology

doi 10.3389/fimmu.2025.1563345

456 views

Original Research

Accepted on 06 Aug 2025

Rational Design of an Epitope-Centric Vaccine Against Pseudomonas aeruginosa Using Pangenomic Insights and Immunoinformatics Approach

in Vaccines and Molecular Therapeutics

Santhosh Mudipalli Elavarasu
Sasikumar K

Frontiers in Immunology

doi 10.3389/fimmu.2025.1617251

217 views

Original Research

Published on 06 Aug 2025

Recombinant SADS-CoV as a vector for porcine epidemic diarrhea vaccine development

in Vaccines and Molecular Therapeutics

Xiaoling Yan
Xiaoli Zhang
Xiaocheng Lyu
Yaoyao Zheng
Qianniu Li
Xiaoya Zhao
Jun Fu
Jingyun Ma

Frontiers in Immunology

doi 10.3389/fimmu.2025.1633661

595 views

Review

Published on 06 Aug 2025

Immune organoids: emerging platforms for modeling and analyzing human adaptive immunity

in Vaccines and Molecular Therapeutics

Tianlong Li
Dingkun Peng
Meng Yao
Meilin Li
Yijing Wang
Su Li
Ding Zhang
Bo Yang
Hua-Ji Qiu
Lian-Feng Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1632117

726 views

Review

Accepted on 04 Aug 2025

Advances in Molecular Adjuvants for Nucleic Acid Vaccines

in Vaccines and Molecular Therapeutics

Casey E Hojecki
Nicholas J Tursi
Cory Livingston
David Weiner
Ebony Gary

Frontiers in Immunology

doi 10.3389/fimmu.2025.1646800

160 views

Original Research

Accepted on 04 Aug 2025

Antibodies elicited by altSonflex1-2-3 GMMA vaccine are bactericidal against a panel of drug-resistant Shigella clinical isolates

in Vaccines and Molecular Therapeutics

Elena Boero
Roberta Di Benedetto
Giacomo Vezzani
Renzo Alfini
Pieter-Jan Ceyssens
Giannoula S. Tansarli
Ferric C. Fang
Carla Fontana
Alberto Rossi
Stefania Carrara

Frontiers in Immunology

doi 10.3389/fimmu.2025.1652460

134 views

Original Research

Accepted on 04 Aug 2025

Risk of Developing Juvenile Idiopathic Arthritis After Quadrivalent HPV Vaccination: A Retrospective Cohort Study Using the TriNetX U.S. Network

in Vaccines and Molecular Therapeutics

WEN-YU WU
Hsin-Hua Chen
Ming-Chin Tsai
Yung-Chieh Huang
Jun-Peng Chen
Lin-Shien Fu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1621939

148 views

Original Research

Published on 04 Aug 2025

Neutralizing antibody response to different COVID-19 vaccines in Brazil: the impact of previous infection and booster doses

in Vaccines and Molecular Therapeutics

Beatriz L. L. Caetano
Paolla B. A. Pinto
Agatha R. Pacheco
Agnes R. Lage
Aline S. G. Pereira
Amanda V. P. Nascimento
Thiago R. Machado
Anderson Paulino
Thiago L. Medeiros
Lorena O. Fernandes-Siqueira

Frontiers in Immunology

doi 10.3389/fimmu.2025.1603612

721 views

Original Research

Published on 01 Aug 2025

Evaluation of the viability and functionality of human peripheral blood mononuclear cells cryopreserved up to 2 years in animal-protein-free freezing media compared to the FBS-supplemented reference medium

in Vaccines and Molecular Therapeutics

Frédérique Jantet-Blaudez
Joseline Ruiz
Sylviane Gautheron
Anke Pagnon

Frontiers in Immunology

doi 10.3389/fimmu.2025.1627973

667 views

Original Research

Published on 01 Aug 2025

The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases

in Vaccines and Molecular Therapeutics

Wanqin Tang
Xi Lu
Zhongkui Zhu
Dan Yu
Huaxian Liu
Yufei Song
Lu Shen
Yang Yu
Yanwei Zhao
Yan Xie

Frontiers in Immunology

doi 10.3389/fimmu.2025.1624095

806 views

Original Research

Published on 01 Aug 2025

Autovaccine immunoprophylaxis in patients with neurogenic bladder experiencing recurrent urinary tract infections

in Vaccines and Molecular Therapeutics

Miguel Ángel Bonillo-García
Domingo Guzmán Ordaz-Jurado
Juan Ortiz-Salvador
Josep Oriol Colet-Guitert
Eduardo Morán-Pascual
Esther Martínez-Cuenca
Salvador Arlandis-Guzmán

Frontiers in Immunology

doi 10.3389/fimmu.2025.1626422

536 views

Original Research

Published on 31 Jul 2025

Dose-sparing effects of novel adjuvants and aluminum hydroxide on two different vaccines in a neonatal mouse model

in Vaccines and Molecular Therapeutics

Jenny Lorena Molina Estupiñan
Poorya Foroutan Pajoohian
Gabriel Kristian Pedersen
Dennis Christensen
Serena Marchi
Emanuele Montomoli
Stefanía P. Bjarnarson
Ingileif Jonsdottir
Audur Anna Aradottir Pind

Frontiers in Immunology

doi 10.3389/fimmu.2025.1646677

917 views